Evidence map›Paper›PMID 36969402›Full record

ReviewACS omega2023

Fuzzy Drug Targets: Disordered Proteins in the Drug-Discovery Realm.

Suman Saurabh, Karthik Nadendla, Shubh Sanket Purohit, Ponnurengam Malliappan Sivakumar, Sibel Cetinel

Open access · goldFull text readReview
In one paragraph

Review in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. The N-Terminal Extension of theAntibiotics (Basel, Switzerland) · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Suman SaurabhMolecular Sciences Research Hub, Department of Chemistry, Imperial College London, London W12 0BZ, U.K.
Karthik NadendlaCenter for Misfolding Diseases, Yusuf Hamied Department of Chemistry, Lensfield Road, University of Cambridge, Cambridge CB2 1EW, U.K.
Shubh Sanket PurohitDepartment of Clinical Haematology, Sahyadri Superspeciality Hospital, Pune, Maharashtra 411038, India.
Ponnurengam Malliappan SivakumarInstitute of Research and Development, Duy Tan University, Da Nang 550000, Vietnam.ORCID https://orcid.org/0000-0002-5880-9596
Sibel CetinelNanotechnology Research and Application Center (SUNUM), Sabanci University, Istanbul 34956, Turkey.ORCID https://orcid.org/0000-0003-0248-9447
Sabancı Üniversitesi · TRImperial College London · GBSahyadri Hospital · INUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intrinsically disordered proteins (IDPs) and regions (IDRs) form a large part of the eukaryotic proteome. Contrary to the structure-function paradigm, the disordered proteins perform a myriad of functions

Identifiers

PMID36969402
PMCPMC10034788
OpenAlexW4323565634

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read9
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.